Dupilumab, Eczema Immunomodulatory Therapies May Not Increase Risk of Severe COVID-19

Patients with atopic dermatitis may not face an increased risk of COVID-19 complications—even if infected while on systemic immunomodulatory therapy. In new late-breaking session data presented at the American Academy…